Liver transplantation with allografts from hepatitis B core antibody-positive donors: A new approach

Liver Transplantation

Volumn 9, Issue 9, 2003, Pages 916-920

  Fábrega, Emilio ^a   García Suarez, Covadonga ^a   Guerra, Armando ^a   Orive, Aitor ^a   Casafont, Fernando ^a   Crespo, Javier ^a   Pons Romero, Fernando ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; HEPATITIS B CORE ANTIBODY; LAMIVUDINE; TACROLIMUS; VIRUS DNA;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORGAN DONOR; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; SERODIAGNOSIS; VIRUS TRANSMISSION;

EID: 10744220904     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50190     Document Type: Article

References (35)

1. Castells L, Vargas V, Rodríguez-Frías F, Allende H, Jardi R, Margarit C, et al. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc 1999;31:2464-2465.
2. Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-Hbc positivity in the donor population. Liver Transpl 2001;7:51-58.
3. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infetion after liver transplantation. J Hepatol 1997;26:517-526.
4. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997;113:1668-1674.
5. Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient liver. Liver Transpl Surg 1997;3:105-111.
6. Safadi R, E'id A, Ilan Y, Ashur Y, Jurim O, Shouval D. Natural course of de novo hepatitis B virus infection in liver transplant recipient. Transpl Proc 1997;29:2677-2679.
7. Manzarbeitia C, Reich D, Ortiz J, Rothstein K, Araya VR, Munoz SJ. Safe use of liver donors with positive hepatitis B core antibody. Liver Transpl 2002;8:556-561.
8. Fabia R, Levy MF, Crippin J, Tillery W, Netto GJ, Aguanno J, et al. De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg 1998;4:119-127.
9. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-146.
10. Dodson SF, Issa S, Araya V, Gayowsky T, Pinna A, Eghtesad B, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997;64:1582-1584.
11. Uemoto S, Sugiyawa K, Marusawa H, Inomata Y, Asonuma K, Egawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-499.
12. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59:230-234.
13. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allograft from anti-HBc-positive donors. Transplantation 1999;68:1058-1061.
14. Holt D, Thomas R, Van Thiel D, Brems JJ. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002;137:572-576.
15. Chen YS, Wang CC, de Villa VH, Wang SH, Cheng YF, Huang TL, et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002;16:405-409.
16. Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997;349:20-22.
17. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714-717.
18. Brechot C, Kremsdorf D, Paterlini P, Thiers V. Hepatitis B virus DNA in HbsAg-negative patients. Molecular characterization and clinical implications. J Hepatol 1991; 13(Suppl 4):549-555.
19. Crespo J, Lozano JL, Carte B, de las Heras B, de la Cruz F, Pons-Romero F. Viral replication in patients with concomitant B and C hepatitis infection. Eur J Clin Microbiol Infect Dis 1997;16:445-451.
20. Crespo J, Fábrega E, Casafont F, Rivero M, de las Heras G, de la Peña J, et al. Severe clinical course of de novo hepatitis B infection after liver transplantation. Liver Transpl Surg 1999;5:175-183.
21. Radomski JS, Moritz MJ, Armenti VT, Munoz SJ. Hepatitis B transmission from a liver donor who tested negative for hepatitis B surface antigen and positive for hepatitis B core antibody. Liver Transpl Surg 1996;2:130-131.
22. Wong PY, Marinos G, Peakman M, Tredger JM, Lau JY, Vergani D, et al. FK506 in liver transplantation for chronic hepatitis B: In vitro studies on lymphocyte activation and virus replication. Liver Transpl Surg 1995;1:362-370.
23. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Fffects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981;81:987-991.
24. Rakela J, Redeker AG, Weliky B. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 1983;84:956-960.
25. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A 1986;83:1627-1631.
26. Dhedin N, Douvin C, Kuentz M, Saint Marc MF, Reman O, Rieux C, et al. Reverse seroconversion of hepatitis B after allogenic bone marrow transplantation: A retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998;15:616-619.
27. Delmonico FL, Snydman DR. Organ donor screening for infectious diseases: Review of practice and implications for transplantation. Transplantation 1998;65:603-610.
28. Turner DP, Zuckerman M, Alexander GJ, Waite J, Wreghitt T. Risk of inappropiate exclusion of organ donors by introduction of hepatitis B core antibody testing. Transplantation 1997;63: 775-777.
29. Pasquinelli C, Laure F, Chatenoud L, Beaurin G, Gazengel C, Bismuth H, et al. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and-negative patients with acute and chronic liver disease. J Hepatol 1986;3:95-103.
30. Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation 1990;49:1155-1158.
31. Marusawa H, Uemoto S, Hijikata M, Tanaka K, Ueda Y, Shimotohno K, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000;31:488-495.
32. Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L, et al. Transplantation of livers from HBcAb-positive donors into HBcAb-negative recipients: A strategy and preliminary results. Clin Transplant 2001;15(Suppl 6):55-58.
33. Van Thiel DH, De Maria N, Colantoni A, Friedlander L. Can hepatitis B core antibody positive livers be used safely for transplantation: Hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody-positive. Transplantation 1999;68:519-522.
34. Angus PW, McCaughan GW, Gane EJ, Crawford DH, Harley H. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl 2000;6:429-433.
35. Lowell JA, Burgerss S, Shenoy S, Peters M, Howard TK. Mercury poisoning associated with hepatitis-B immunoglobulin. Lancet 1996;347:480.